Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter Read more about Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter
Study of the Glutaminase Inhibitor CB-839 in Leukemia Read more about Study of the Glutaminase Inhibitor CB-839 in Leukemia
Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL Read more about Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL
Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan Read more about Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan
SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission Read more about SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases Read more about Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma Read more about Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Read more about Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery Read more about Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer Read more about S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer